Weight Loss & MetabolicPeer Reviewed

Real-World Effectiveness of Tirzepatide versus Semaglutide on HbA1c and Weight in Patients with Type 2 Diabetes.

Authors (7)
Meredith M HoogEli Lilly and Company, Indianapolis, IN, USA. meredith.hoog@lilly.com.
Carlos VallarinoEli Lilly and Company, Indianapolis, IN, USA.
Juan M MaldonadoEli Lilly and Company, Indianapolis, IN, USA.
Michael GrabnerCarelon Research, Wilmington, DE, USA.
Diabetes therapy : research, treatment and education of diabetes and related disorders
Unknown
Published
Oct 13, 2025
View Original

Abstract

Abstract not available - data parsing issue resolved

Keywords

GIPGLP-1HbA1cIncretinReal-world evidenceSemaglutideTirzepatideType 2 diabetesWeight loss

Article Metrics

Sourcepubmed

Related Research

Explore more articles in this research category to discover related studies and findings.

View more in Weight Loss & Metabolic